Company: SLMT
Filing Date: 2025-11-19
Form Type: F-3ASR
Source: 0001213900-25-112727
Chunk: 18

Company: Brera Holdings PLC
Filing Date: 2025-11-19
Form: F-3ASR
Chunk 18
---
 within 30 days of the closing of the WPA Investor Purchase registering the resale of the Class B Ordinary Shares underlying the WPA Investor Warrant.

The registration statement of which this prospectus forms a part is being filed in part to satisfy our obligations under the WPA Investor Registration Rights Agreement.

On September 23, 2025, the Company entered into a Warrant Purchase Agreement (the “DM Warrant Purchase Agreement”) with an entity (the “DM Purchaser”) owned and controlled by Mr. McClory pursuant to which the Company will offer and sell a Class B Ordinary Share purchase warrant to purchase 200,000 Class B Ordinary Shares to the DM Purchaser (the “DM Warrant”) for $2,000 (the “DM Warrant Purchase”). The closing of the DM Warrant Purchase occurred simultaneously with the closing of the PIPE Offering. The DM Warrant has been exercised in full on a cashless basis. The Class B Ordinary Shares issued upon the exercise of the DM Warrant have been included in the registration statement related to this prospectus pursuant to the DM Registration Rights Agreement 2 (as defined below).

In connection with entering into the DM Warrant Purchase Agreement, on September 23, 2025, the Company and the DM Purchaser entered into a Registration Rights Agreement (the “DM Registration Rights Agreement 2”), pursuant to which the Company agreed to file a registration statement with the SEC, within 30 days of the closing of the DM Warrant Purchase registering the resale of the Class B Ordinary Shares underlying the DM Warrant.

The registration statement of which this prospectus forms a part is being filed in part to satisfy our obligations under the DM Registration Rights Agreement 2.

Resignations and Appointments of Certain Directors and Officers.

Resignation of Directors

Effective September 23, 2025, Dr. Fabio Scacciavillani resigned from the Board of Directors (the “Board”) and as Chief Executive Officer of the Company. Dr. Scacciavillani will continue in his role as Chief Financial Officer.

Additionally, on September 23, 2025, Abhishek Matthews, Christopher Gardner, Giuseppe Pirola and Goran Pandev resigned as members of the Board. Neither Mr. Matthew’s, Mr. Gardner’s, Mr. Pirola’s or Mr. Pandev’s resignation was a result of any disagreement relating to the Company’s operations, policies or practices.

Appointment of Directors

On September 23, 2025, we appointed the following directors